Your session is about to expire
← Back to Search
Hormone Level Management for Obesity
Study Summary
This trial is studying how hormones develop in girls as they age, specifically looking at how weight affects hormone levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2013 Phase 4 trial • 122 Patients • NCT01474915Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your 17-hydroxyprogesterone level is higher than 295 ng/dL.I weigh less than 24 kg.I have had Cushing's syndrome or adrenal insufficiency.I am a female with a BMI in the normal range or above the 95th percentile.My blood tests are mostly normal, though I might have slight changes due to being overweight.I am between 7 and 18 years old, experiencing puberty.Your morning cortisol level is less than 5 micrograms per deciliter.Your hemoglobin level is less than 12 mg/dL and your hematocrit is less than 36%.My lab results are not within the normal range for my age.I weigh at least 24 kg.
- Group 1: Dexamethasone, Cortrosyn
- Approved for 60 Other Conditions - This treatment demonstrated efficacy for 60 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is this trial accommodating participants?
"Affirmative, this clinical trial is actively recruiting subjects- according to the data hosted on clinicaltrials.gov, it was first listed on October 10th 2006 and recently updated July 28th 2022; 84 patients are needed across a single site."
Could you please elucidate the results of prior experiments involving Dexamethasone?
"Currently, 555 clinical trials are being conducted in order to assess the efficacy of Dexamethasone. Of these studies, 143 have progressed to Phase 3 and a total of 18656 locations across America are taking part in this research. The epicentre for this investigation is Elk Grove Village, Illinois."
Does the current research protocol permit enrolment of individuals over 30 years old?
"Patients aged 7 to 18 years old are eligible for inclusion in this study."
What medical conditions can Dexamethasone be prescribed to alleviate?
"Dexamethasone is widely used to treat synovitis, though it can also be administered for ophthalmia and branch retinal vein occlusion-related macular edema."
Are there still openings in this trial for participants?
"According to the records available on clinicaltrials.gov, this study is currently accepting candidates. The initial posting of information was made on October 10th 2006 and it has since been updated as recently as July 28th 2022."
To whom is this clinical trial open?
"This trial seeks to include 84 participants who have sclerocystic ovaries and are between 7-18 years old."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger